Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Global Neurology Clinical Trial Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market ... Read More
-
Global Neurology Clinical Trial Supply, Demand and Key Producers, 2023-2029
... forecast period (2023-2029). This report studies the global Neurology Clinical Trial demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market for Neurology Clinical Trial, and provides ... Read More
-
Ulcerative Colitis (UC) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031
... diseases that cause intestinal inflammation: Crohn's disease (CD) and Ulcerative Colitis (UC). In Ulcerative Colitis (UC), chronic inflammation affects the colon (also known as the large intestine). Initially, Ulcerative Colitis (UC) usually manifests in the ... Read More
-
Mucopolysaccharidosis II (MPS II) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 3,300 diagnosed prevalent cases of MPH-II in 2023 in the 16 major markets. The marketed drugs space for MPS II include molecules targeting iduronate 2 sulfatase (IDS) replacement. R&D activity within the MPS ... Read More
-
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... of OCD in 2023 in the 16 major markets. The marketed drugs space for OCD is made up of small molecules. Their modes of action are mainly gamma-aminobutyric acid type A receptor subunit agonists and ... Read More
-
Respiratory Syncytial Virus (RSV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... diagnosed seropositive prevalent cases of RSV across the 8MM in 2023. Currently, there are only three marketed drugs for RSV: two monoclonal antibodies (palivizumab and nirsevimab) and one antiviral drug (ribavirin). R&D activity within the ... Read More
-
Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031
... Japan, and China) and includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for myelofibrosis (MF). ... Read More
-
Global Pompe Disease Treatment Market Report and Forecast 2023-2031
... at a CAGR of 4.8% during the forecast period of 2023-2031 to reach a value of USD 1.74 billion by 2031. The market growth can be attributed to the increasing prevalence of Pompe disease, advancements ... Read More
-
Global Contract Research Organization Market - Market Size & Forecast To 2032
... during the forecast period from 2023 to 2032. The Contract Research OrganizationMarket research report discusses the importance of the segments as well as the regional markets. An accurateoverview for different segments and regions has been ... Read More
-
Obesity Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031
... adipose tissue. It results from an intricate interplay between environmental, genetic, and psychosocial factors, which together arbitrate the balance between food intake and expenditure of energy. Obesity is a primary cause of many life-threatening diseases, ... Read More
-
Alzheimer's Disease Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Alzheimer's Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Aneurysm Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Aneurysm Clinical trials scenario. This report provides top line data relating to the clinical trials on Aneurysm. Report includes ... Read More
-
Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Zollinger-Ellison Syndrome (Gastrinoma) Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Hypoglycemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Hypoglycemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypoglycemia. Report includes ... Read More
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... (AML, Acute Myeloblastic Leukemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Kaposi SarcomaAcute Myelocytic Leukemia (AML, Acute Myeloblastic ... Read More
-
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario. This report provides ... Read More
-
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Non-Alcoholic Steatohepatitis (NASH) Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Post-Polycythemia Vera Myelofibrosis (PPV-MF) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Post-Polycythemia Vera Myelofibrosis (PPV-MF) Clinical trials scenario. This report provides top line data ... Read More
-
Prader-Willi Syndrome (PWS) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Prader-Willi Syndrome (PWS) Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Attention Deficit Hyperactivity Disorder (ADHD) Clinical trials scenario. This report provides ... Read More
-
In Silico Clinical Trials Market, By Therapeutic Area (Oncology, Infectious Disease, Cardiology, Neurology, Diabetes, and Other Therapeutic Areas), By Industry (Medical Devices and Pharmaceutical), By Phase (Phase I, Phase II, Phase III, and Phase IV), And By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... And By Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 In silico clinical trials refers to the development of a patient-specific models ... Read More
-
Global Clinical Trial Planning and Design Services Market Growth (Status and Outlook) 2023-2029
... in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Clinical Trial Planning and Design Services is estimated to increase from US$ million in 2022 ... Read More
-
Global Clinical Trials Outsourcing Market 2023-2029
... and specialized vendors who provide various clinical trial services, such as patient recruitment, site monitoring, data management, statistical analysis or regulatory filing. Outsourcing clinical trials allows pharmaceutical, biotechnology, and medical device companies to focus on ... Read More
-
eClinical Solutions Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Adoption of Electronic Data Capture (EDC) Systems in Clinical ... Read More
-
2023 Global Forecast for Efficacy Testing Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. Published annually, this report provides a unique ... Read More
Research Assistance
